Article Text
Abstract
Background China has enacted subnational smoke-free legislations, which requires compliance evaluations to provide data for future implementation planning. This study comprehensively assessed smoke-free regulation compliance in Xining in Western China.
Methods Conducted in November and December 2023, the study used a mixed-methods design. Quantitative surveys of observing the existence of ‘no evidence of smoking’ were completed by trained investigators in 1007 venues (including 2553 indoor and 55 outdoor areas). PM2.5 concentration assessments of evidence of smoking were performed in 48 venues. Staff interviews on perceptions and implementation of the regulations were conducted in 94 venues.
Results In the quantitative survey, the compliance rate of ‘no evidence of smoking’ in indoor areas ranged from 65.2% to 100% by venue types, with public transportation vehicles (100%) and educational institutions (90%) showing the highest rates and leisure/entertainment/accommodation venues showing the lowest. The compliance rate in outdoor areas was 88.5% for health institutions and 96.4% for educational institutions. The PM2.5 monitoring found six venues (one hospital and five leisure/entertainment/accommodation venues) had an average PM2.5 concentration level exceeding China’s air quality standard, which were highly likely caused by people smoking. Qualitative interviews revealed that lack of commitment and knowledge to regulations among venue staff and non-cooperation of smoking clients might be the main reasons contributing to unsatisfactory compliance.
Conclusion The study provided empirical data on the compliance with local smoke-free regulations in Xining and identified a room for improvement. Efforts should be made to raise public awareness of smoke-free regulations and strengthen regulations’ enforcement and supervision.
- Public policy
- Secondhand smoke
- Surveillance and monitoring
Data availability statement
All data relevant to the study are included in the article or uploaded as supplementary information.
Statistics from Altmetric.com
Data availability statement
All data relevant to the study are included in the article or uploaded as supplementary information.
Footnotes
Contributors SL supervised the study and was responsible for the conceptualisation of the research methodology. JZ, LX, RL, XW, KW, EK and DB contributed to the refinement of the research methodology and provided technical support. YZ, SW and JZ contributed to the design of the questionnaire. YZ, SW, JZ, QL, XS, XZ, PM, LX and SL helped to organise and coordinate the research fieldwork. YZ, SW and XS oversaw the data collection process and ensured the integrity and quality of the data gathered. YZ, SW, XS and YX assisted in the preliminary analysis of the data and interpretation of the results. YZ, YX, SW, XS and QL contributed to the initial drafting of the manuscript. YZ, RL, XW, KW, EK, SW, JZ and CR were responsible for the final review and editing of the manuscript, ensuring that the language, grammar, and style were consistent and professional. SL, YZ and SW oversaw the finalisation of the manuscript. All authors were responsible for the decision to submit the manuscript for publication. SL is the guarantor.
Funding This work was supported by Research Fund, Vanke School of Public Health, Tsinghua University [No. 100010001].
Map disclaimer The inclusion of any map (including the depiction of any boundaries therein), or of any geographic or locational reference, does not imply the expression of any opinion whatsoever on the part of BMJ concerning the legal status of any country, territory, jurisdiction or area or of its authorities. Any such expression remains solely that of the relevant source and is not endorsed by BMJ. Maps are provided without any warranty of any kind, either express or implied.
Competing interests The authors declare no conflicts of interest or relevant financial or non-financial relationships related to this work.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.